aTyr Pharma Inc (NASDAQ:LIFE)

2.40
Delayed Data
As of Apr 24
 +0.05 / +2.13%
Today’s Change
2.30
Today|||52-Week Range
6.50
-31.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization226.0K174.0K152.0K161.0K
 
 
 
 
 
 
Operating ExpensesGross Income-226.0K-174.0K-152.0K-161.0K
 
 
 
 
 
General Expenses13.0M11.7M10.7M11.0M
 
 
 
 
 
Research And Development9.2M8.4M7.1M5.3M
 
 
 
 
 
Total Operating Expenses13.2M11.9M10.8M11.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.2M-11.9M-10.8M-11.2M
 
 
 
 
 
Other Expenses-194.0K-231.0K-363.0K-274.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.4M-12.1M-11.2M-11.5M
 
 
 
 
 
Net Income-13.4M-12.1M-11.2M-11.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.7M23.8M25.8M29.8M
 
 
 
 
 
Shares To Calculate EPS Diluted23.7M23.8M25.8M29.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.56-$0.51-$0.43-$0.39
 
 
 
 
 
EPS Diluted-$0.56-$0.51-$0.43-$0.39